Massachusetts physician accused of $10.6M in billing fraud

A psychiatrist in Natick, Mass., was arrested Dec. 10 in connection with charges that he billed Medicare and private payers for more than $10 million in treatments he did not provide, according to the Department of Justice

Advertisement

Between January 2015 and December 2018, Gustavo Kinrys, MD, allegedly billed Medicare and private insurers for psychotherapy sessions and transcranial magnetic stimulation therapy sessions he never provided. He claimed more than 8,000 of the TMS sessions were provided to 75 patients who never received a single session of therapy, according to the Justice Department. 

Federal prosecutors further alleged that Dr. Kinrys made several false statements to his patients, the billing company with which he worked and insurers. He took steps to conceal the alleged billing fraud scheme from private insurers and HHS. 

Dr. Kinrys was indicted on seven counts of wire fraud, six counts of false statement relating to healthcare matters, and one count each of falsification of documents and obstructing a criminal healthcare investigation. 

More articles on legal and regulatory issues:
California system alleges Kaiser tried to monopolize health insurance market
Former owner of healthcare staffing firm charged with wage-fixing
Ousted California hospital CEO arrested on felony charges

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Reconsider What’s Possible: Enterprise RCM and the Pro-Fee Practice

Tuesday, July 28
11:00 AM - 12:00 PM CDT

Presenters: Garett Kreitz, Med-MetrixJohn Stefanowicz, Med-Metrix

Advertisement

Next Up in Legal & Regulatory Issues

Advertisement

Comments are closed.